Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
Read More

Tetra Bio-Pharma: Positive Clinical Data From Both Phase 2 Clinical Trials Of QIXLEEF For Cancer Pain

Tetra Bio-Pharma Inc. (TSX: TBP) (OTCQB: TBPMF), a leader in cannabinoid-derived drug discovery and development announced on Monday that it produced positive initial clinical data from its ongoing Phase 2 clinical trials of QIXLEEF™ (REBORN©1 and PLENITUDE©), which

TBPMF

Read More

Ayurcann Holdings Corp. Reports Third Consecutive Quarter of Positive Operating Income

Ayurcann Holdings Corp. (CSE: AYUR) (FSE: 3ZQ0) a Toronto-based cannabis extraction company specializing in processing and manufacturing cannabis products, reported its financial and operating results for the three months ended September 30, 2021, in a press release on Monday, Nov. 29. Highlights For The First Quarter Ended September 30, 2021

CSE:AYUR